2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 62.742 | 70.848 | 41.867 | 61.907 | 74.335 | 40.275 | 22.523 | 43.448 | 34.008 | 174.476 |
Total Income - EUR | 63.880 | 72.602 | 42.712 | 62.119 | 75.298 | 41.206 | 40.842 | 46.944 | 34.008 | 187.276 |
Total Expenses - EUR | 52.535 | 51.561 | 41.070 | 39.082 | 47.381 | 30.578 | 35.055 | 39.064 | 30.940 | 171.823 |
Gross Profit/Loss - EUR | 11.346 | 21.041 | 1.642 | 23.037 | 27.917 | 10.627 | 5.787 | 7.880 | 3.068 | 15.453 |
Net Profit/Loss - EUR | 9.434 | 20.319 | 1.218 | 22.416 | 27.165 | 10.288 | 5.674 | 7.121 | 2.758 | 9.997 |
Employees | 3 | 4 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vaflorin S.r.l.
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 59.354 | 53.861 | 48.922 | 45.951 | 44.512 | 41.621 | 39.450 | 41.832 | 41.485 | 207.081 |
Current Assets | 10.593 | 7.265 | 10.187 | 36.466 | 15.914 | 26.905 | 33.673 | 21.435 | 25.595 | 104.339 |
Inventories | 3.364 | 3.212 | 3.375 | 2.913 | 1.387 | 1.018 | 4.101 | 836 | 1.697 | 20.018 |
Receivables | 1.860 | 1.587 | 1.588 | 1.753 | 2.883 | 21.110 | 15.561 | 5.274 | 4.996 | 33.650 |
Cash | 5.369 | 2.466 | 5.223 | 31.800 | 11.645 | 4.777 | 14.011 | 15.325 | 18.902 | 50.671 |
Shareholders Funds | -11.587 | 8.851 | 9.919 | 32.153 | 58.695 | 67.870 | 72.039 | 59.065 | 61.644 | 294.916 |
Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 200 |
Debts | 81.534 | 52.276 | 49.089 | 50.126 | 1.731 | 656 | 1.085 | 4.202 | 5.436 | 16.504 |
Income in Advance | 0 | 0 | 100 | 138 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "5610 - 5610" | |||||||||
CAEN Financial Year |
5610
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Vaflorin S.r.l.